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Abstract 
 
DNA is labile and constantly subject to damage. In addition to external mutagens, 
DNA is continuously damaged by the aqueous environment, cellular metabolites and 
is prone to strand breakage during replication. Cell duplication is orchestrated by the 
cell division cycle and specific DNA structures are processed differently depending 
on where in the cell cycle they are detected. This is often because a specific 
structure is physiological in one context, for example during DNA replication, while 
indicating a potentially pathological event in another, such as interphase or mitosis. 
Thus, contextualising the biochemical entity with respect to cell cycle progression 
provides information necessary to appropriately regulate DNA processing activities. 
We review the links between DNA repair and cell cycle context, drawing together 
recent advances.  
 
 
Introduction 
During the past few decades the DNA repair field moved from considering repair 
simply as a variety of enzymatic activities and pathways towards understanding of 
how the relevant DNA transactions act in the context of the cellular environment and 
the cell division cycle. In simple terms the cell cycle is driven by cyclin dependent 
kinases (CDKs) that form a negative feedback loop oscillator [1]. The negative 
feedback is defined by the fact that high CDK activity drives CDK destruction. Mitotic 
CDKs have two core subunits, a cyclin that is periodically degraded and a kinase 
that is regulated by phosphorylation. When cells are born into G1, CDK levels are 
very low because the Anaphase Promoting Complex (APC/C; a specialised ubiquitin 
ligase) has been activated by the high CDK required for mitosis and has destroyed 
the mitotic cyclins. APC/C remains active in G1 and the consequent low CDK activity 
essentially defines G1. 
 
Mammalian cells enter from G1 into S phase in response to the expression of D-type 
cyclins induced by growth factor signalling pathways. This causes overall CDK levels 
to increase and consequently the APC/C is inhibited. During S phase, mitotic cyclins 
are transcribed and translated and CDK activity thus continues to increase [2], 
although CDK activity is attenuated by phosphorylation of the kinase subunit by 
WEE1-related enzymes. As S phase reaches completion, CDK levels continue to 
increase and cells transit into G2. While there is not a defined point where S phase 
ends and G2 starts, it has historically been considered that the completion of bulk 
DNA synthesis, as measured by flow cytometry, marks the beginning of G2. More 
recently, it has become apparent that late replicating regions, including fragile sites, 
are still being replicated during “G2” in many cells [3].  
 
The decision of when to enter mitosis depends on the continued increase in cyclin 
levels, the attenuation of WEE1-like kinase activities by CDK and an increase in 
CdDC25 phosphatase activity (that counteracts WEE1-dependent CDK 
phosphorylation). These events form positive feedback loops that intersect with the 
negative feedback mechanism to provide bi-stability to the oscillator. The balance of 
positive and negative activities, and thus the precise timing of mitosis, are modulated 
by regulatory mechanisms during which CDK interfaces with other mitotic [4] and 
checkpoint [5] kinases. Once the bi-stable switch has been thrown [6], cells can be 
considered to be committed to mitosis. Because high CDK levels activate the APC/C 
(the negative feedback loop), high CDK activity programs its own destruction by 
APC/C –dependent cyclin degradation following the metaphase/anaphase transition. 
Thus, a new cycle begins [7]. 
 
It was first shown in fission yeast that CDK activity was required for efficient double 
strand break (DSB) repair [8]. Mutants impaired for cyclin B, the sole mitotic cyclin in 
fission yeast, were observed to be sensitive to DNA damage and unable to 
appropriately accumulate RPA foci in response to DSBs (see Figure 1). Subsequent 
work in budding yeast demonstrated that CDK phosphorylation directly regulated 
resection initiators [9,10] and other enzymatic activities that promote DSB resection 
[11,12]. Similar phenomena were subsequently shown to be conserved in human 
cells [13-18]. 
 
DSB repair pathway choice: G1 v G2.  
DSBs are the most toxic DNA lesions [19]. In a haploid organism, a single 
unrepaired or misrepaired DSB is generally lethal. In diploid organisms, a single DSB 
may not be cell lethal, but if unrepaired or misrepaired can result in loss of 
heterozygosity (LOH) and/or generate gross chromosomal rearrangements (GCRs). 
There are two main pathways to repair DSBs (Figure 1), homologous recombination 
(HR), which is generally error-free, and Non Homologous End Joining (NHEJ) that 
frequently introduces small deletions or insertions. In G1 cells there is no sister 
chromatid to use as an HR template and cells therefore use NHEJ [20]. Even in 
diploid cells the use of a homologous chromosome for HR is not favoured because 
the search for homology is prone to result in non-allelic HR at repeat sequences, 
potentially generating GCRs and/or LOH.  
 
A key determinant in the choice between HR and NHEJ is whether the DSB is 
resected to generate the 3’ ssDNA tail essential for strand invasion [21]. Once 
resected, repair of a DSB by NHEJ is blocked and repair by mechanisms other than 
HR (for example single strand annealing or microhomology-mediated end joining) 
are likely to result in loss of genetic material and/or GCRs. To prevent inappropriate 
attempts at HR, cells thus regulate resection onset (Figure 1). In human cells this 
pathways choice is controlled by the association of 53BP1 with the chromatin 
surrounding the break site, which inhibits resection (Figure 2). 53BP1-dependent 
resection inhibition is counteracted in G2 by BRCA1 and a number of BRCA1-
associated factors such as PTIP and RIF1 [20]. 
 
Since a defining characteristics of G1 is low CDK and high APC/C it is unsurprising 
that multiple enzymes required for efficient resection, plus some downstream HR 
factors, are positively regulated by CDK-dependent  phosphorylation. Some may 
also be degraded directly by APC/C [22]. A key CDK target is CtIP, a regulator of the 
MRE11/RAD50/NBS1 nuclease. Human CtIP is recruited to DSBs and must be 
phosphorylated on T847 to be active [14]. However, expressing CtIP-T847E (a 
phospho-mimetic and thus constitutively activated allele) is insufficient to drive HR. 
This is because a second mechanism prevents the recruitment of the activator of 
resection, BRCA1 [23].  
 
BRCA1 associates at DSB sites and promotes HR by counteracting 53BP1-
dependent resection inhibition, activating CtIP [24,25] and recruiting BRCA2 (a 
modulator of the key downstream HR protein RAD51). The recruitment of BRCA2 by 
BRCA1 is mediated through an interaction between BRCA1 and the BRCA2-
associated protein, PALB2. A Cullin 3 ubiquitin ligase, CRL3KEAP1, constitutively 
targets the BRCA1 interacting domain of PALB2. This ubiquitylation does not 
promote PALB2 degradation, but prevents the BRCA1-PALB2 interaction. To 
facilitate BRCA2 recruitment, PALB2 ubiquitylation by CRL3KEAP1 must be 
counteracted by a protease, USP11. To ensure that PALB2 cannot interact with 
BRCA1 in G1 cells (and thus cannot initiate HR in G1 by recruiting BRCA2) USP11 
is degraded in G1 cells. This is enforced by a Cullin 4-dependent Ub ligase that is 
only active in G1 cells. Therefore, PALB2 ubiquitylation is a second mechanism that 
inhibits HR in G1 and is complementary to the requirement for CDK phosphorylation 
of key resection initiation proteins such as CtIP. Combining expression of CtIP-
T847E (over-riding CDK regulation of CtIP) with stabilisation of USP11 allows HR in 
G1 cells. 
 
DNA repair in S phase. 
Some aspects of DNA repair in S phase are specific by definition. For example, 
lesions such as inter-strand crosslinks (ICLs) are mainly detected during S phase 
when encountered by the replication machinery [26,27]. ICLs detected by the 
replisome initiate a complex set of enzymatic reactions that, as with many HR events 
in S phase, are regulated by the Fanconi Anaemia (FA) pathway [28]. Similarly, 
unrepaired base lesion encountered during DNA replication can be bypassed by the 
replisome and the resulting gap in the newly synthesised strand filled by post-
replication repair (PRR). There are two main PRR pathways; synthesis across the 
lesion by polymerases with reduced fidelity or an HR-based template switching 
mechanism that copies the information from the newly synthesised strand of the 
sister chromatid [29]. PRR pathways are initiated in S phase by the ubiquitylation of 
PCNA, although it has become clear that many of the gap repair events are 
occurring in G2 [30,31]. 
 
S phase provides the cell with a unique problem: a proportion of DNA is replicated 
while other segments are not. How does a cell distinguish a lesion in replicated as 
opposed to unreplicated chromatin? In G1 cells Histone H4 in unreplicated chromatin 
is dimethylated on Lysine 20 (H4K20me2). During replication, newly incorporated H4 
is unmethylated on this residue [32]. This provides a mark (H4K20Me0) that allows 
the association of the TONSL protein (Figure 1). Along with MMS22L, TONSL can 
load RAD51 and is a facilitator of HR [33,34]. Thus, newly replicated DNA is HR-
competent. In contrast, H4K20me2 cannot associate with TONSL, but can facilitate 
the binding of 53BP1: in response to a DNA lesion H2A is ubiquitylated on lysine 15 
(H2AK15Ub) by RNF168 [35] and co-operates with (constitutive) H4K20me2 to 
provide a docking platform for 53BP1. Because H4K20Me2 is diluted by a factor of 
two in newly replicated DNA, the affinity of 53BP1 at DNA damage sites is 
decreased, attenuating the ability of 53BP1 to block the HR. This likely synergises 
with TONSL/MMS22L association to facilitate HR and limit NHEJ when damage 
occurs in newly replicated chromatin [36]. Thus, cells can distinguish replicated from 
unreplicated DNA in S phase, helping the appropriate processing of DNA lesions.  
 
DNA repair in Mitosis. 
Early experiments showed that introducing DNA damage into early mitotic cells 
resulted in a transient reversal of mitosis [37]. However, until quite recently it was 
considered that once the decision to enter mitosis has been made DNA damage 
responses became largely irrelevant. It is now recognised that, when cell transit into 
mitosis, DNA damage responses are significantly modified. For example, in 
response to DSBs ATM activation and H2AX phosphorylation still occur (in fact more 
so because some counteracting phosphatases are downregulated by APC/C), but 
RNF8/RNF168-dependent ubiquitylation is decreased [38] and DSB end resection 
prevented by mechanisms that include CtIP hyper-phosphorylation [39,40]. NHEJ is 
also attenuated in mitosis by via XRCC4 phosphorylation [41]  and a range of key 
downstream HR proteins, including BRCA2 and RPA, are also phosphorylated, 
altering their properties [42]. 
 
It has recently become clear that a small number of stalled (or ongoing) replication 
events are present in many cells as they enter mitosis. These correlate to common 
fragile sites (CFS), genomic loci that have a tendency to break during mitosis. At 
least a proportion of CFS are defined by being late replicating regions of the genome 
with a paucity of potential replication initiation zones [3]. To minimise the potential for 
these late replication events to generate genetic instability specific mechanisms act 
during mitosis to repair failed replication events and/or minimise the consequent 
genetic instability. Attempts to complete replication as cells enter mitosis have 
recently been recognised by the incorporation of pulsed BrdU label into mitotic 
chromosomes. This requires the activity of MUS81, POLD3 (a subunit of Polymerase 
delta required for its full efficiency) and RAD52, but not RAD51. [43,44]. The DNA 
synthesis that occurs in early mitotic cells is clearly distinct from the canonical 
synthesis observed during S phase and contributes to maintaining genome stability. 
 
In mammalian cells mitosis-specific DNA replication is initiated by the association of 
the structure-specific nuclease MUS81/EME1 (an obligate heterodimer) with 
SLX1/SLX4. MUS81/EME1 and SLX1/SLX4 exist as separate complexes in G1/S 
but come together in late G2/M [45]. This is controlled by MUS81’s association with 
the SAP domain of SLX4, which requires multiple CDK phosphorylation events. The 
MUS81/EME1 - SLX1/SLX4 interaction is likely to modulate function by changing 
MUS81 substrate specificity: SLX4 enhances MUS81/EME1 activity against fork 
structures in vitro by relaxing its substrate specificity [46]. Consistent with a mitotic 
function for MUS81/EME1 against replication structures, inhibition of WEE1 (thus 
promoting premature CDK hyper-activation in S phase) results in catastrophic 
MUS81/EME1-dependent pulverisation of chromosomes. The cell cycle regulation of 
MUS81 nuclease activity appears to be particularly important: MUS81 can also bind 
an alternative EME1-related subunit, EME2. MUS81-EME2 complex only forms in 
G1/S phase and has a distinct function in remodelling replication structures to 
promote fork restart [47,48]. 
 
Additional mitotic-specific repair events have been identified, including the resolution 
of Holiday junctions (HJs) that persist from recombination events that occurred 
during S phase and G2 [49]. Double HJs are, by preference, dissolved by BLM/TOP3 
in G2 – a process that avoids crossovers and thus minimises potential LOH [50]. 
However, single HJs and unprocessed double HJs can persist into mitosis and are 
resolved by either MUS81/EME1-SLX1/SLX4 or Gen1, a HJ resolvase that is also 
activated in mitosis in a CDK-dependent manner [51,52].  
 
Conclusion 
The study of the mechanisms that regulate DNA repair and other DNA damage 
responses through the cell cycle is evolving rapidly. There is an immense amount of 
detail in the literature concerning the regulation of repair and checkpoint signalling 
[53] by cell cycle dependent phosphorylation and ubiquitylation. In the next few years 
we will likely have a clearer understanding of how DNA repair pathway choice for 
DSBs, the most toxic of DNA lesions, is integrated with, and fine-tuned by, the cell 
cycle. We will also develop a more complete understanding of the causes and 
consequences of the genetic instability that results from DNA lesions that persist into 
mitosis and how the intricacies of DNA structure-specific DNA metabolic enzymes 
are contextualised minimise these events. 
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Figure Legends 
 
Figure 1 
The two main pathways of DSB repair. Left: DSB repair by NHEJ. the Ju70/80 dimer 
binds to DNA ends and protects them from nucleases. DNA-PKcs binds to Ku and 
orchestrates end processing and subsequent ligation by DNA ligase IV (Lig4). Right: 
in S phase and G2 cells can repair DSBs through homologous recombination (HR) 
using the sister chromatid as a template. CtIP and MRN are rapidly recruited and 
can initiate resection by removing Ku. Resection is continued by a combination of 
two pathways involving the nucleases, Exo1 or DNA2. The decision whether to 
initiate resection is the key control point between HR and NHEJ (see text for details). 
As DNA is resected, RPA (yellow) is loaded and subsequently Rad51 forms a 
filament on the ssDNA. This performs a homology search and establishes a D-loop 
which allows the initiation of DNA synthesis. 
 
Figure 2 
Simplified schematic of key cell cycle dependent DNA damage responses. Before 
replication (blue background) 53BP1 binds to chromatin at sites of DNA damage and 
inhibits resection and thus HR. This facilitates repair by NHEJ. After a region has 
been replicated (red background) the newly deposited H4 remains unmethylated on 
K20 and allows the binding of TONSL/MMS22L, which helps promote recombination. 
In addition, BRCA1 becomes competent to associate with sites of DNA damage and 
counteracts the inhibitory function of 53BP (see text for mechanistic details). If 
unresolved replication or recombination structures remain when cells enter mitosis 
(green background) the high activity of CDK and other mitotic kinases (such as Polo-
like kinases) modify the function of multiple enzymes to attempt their resolution. 
Thus, a wide variety of DNA damage response and repair enzymes are regulated to 
facilitate distinct responses to otherwise biochemically identical lesions.  
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** Cell cycle kinases regulate DNA damage responses in multiple ways. This paper describes 
one mechanism by which checkpoint signalling is regulated by cell cycle progress to 
appropriately balance the DNA damage response 
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